ArticleThe Journal of pharmacology and experimental therapeutics2012

Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl ester transfer protein transgenic low-density lipoprotein receptor (-/-) mice.

Eva Hambruch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.